Medtronic is a stable medical device company currently trading below analyst price targets and undervalued, with a potential ...

Medtronic (NYSE:MDT) received U.S. FDA clearance for its Stealth AXiS surgical system for cranial and ENT procedures. The platform combines AI enabled planning, navigation, and robotics for use across ...

Medtronic (NYSE: MDT) made a significant neurovascular play earlier this month when it agreed to acquire Scientia Vascular.

Global medical technology firm with diversified therapeutic portfolio Strong institutional backing reflects broad market ...

Medtronic plc (NYSE:MDT) was featured on Mad Money as Jim Cramer shared his take on the stock amid a sliding macro environment. When a caller asked about the stock, Cramer said: I have to tell you, I ...

Medtronic strengthens neurovascular segment with advanced guidewire technologies; Scientia Vascular enhances complex stroke ...

March 10 (Reuters) - Medical device maker Medtronic (MDT.N), opens new tab said on Tuesday it would buy U.S.-based Scientia ‌Vascular in a deal valued at $550 million, expanding its line-up of ...

Medtronic, a global leader in healthcare technology, has been recognized as one of the 2026 World’s Most Ethical Companies® ...

Medtronic's standing as the largest pure-play medical-device maker remains a force to be reckoned with in the medical technology landscape. Medtronic's diversified product portfolio aimed at a wide ...

Medtronic's key catalysts, including Symplicity Spyral, PFA, and Hugo, have promising growth ahead. Click here to read an ...

The latest announcement is out from Medtronic ( (MDT) ).

A photographer takes images next to samples of Medtronic products at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov ...